Philippe Wieczorek Named Minalogic’s Software Director
News Dec 07, 2012
Minalogic has announced that Philippe Wieczorek has been named director of the Software Department.
Wieczorek will be responsible for coordinating and expanding Minalogic’s software development activities, including projects that help cluster members integrate innovative software features in microelectronics and develop smart miniaturized products and solutions.
He most recently served as chief of staff of Hewlett Packard’s Internal Sites Management Team (ISMT) in Grenoble.
In that position, he focused on creating R&D activity and on ISMT’s relationships with institutional players and academics.
At HP, Wieczorek also was an innovation manager for the company’s Communications and Media Solutions business unit, managing international projects.
“Philippe Wieczorek has extensive experience in managing R&D programs and maintaining strong relationships with upstream research organizations that originate many key innovations in micro- and nanotechnologies,” said Minalogic CEO Jean Chabbal.
Chabbal continued, “His combination of innovation expertise and his R&D network will be a big asset for Minalogic and its members, and we are very pleased he is joining us.”
Earlier in his career, Wieczorek worked in the network and telecommunication fields, where he held engineering positions ranging from software development to engineering manager. He also worked for five years at Cap Gemini S.A., the leading French IT services company.
He holds a M.S. in computer science from McGill University in Montreal, Canada, and an engineering degree from INSA Lyon, France.
Nano-tech Diagnostic Can Indicate Cancer or Thrombotic Risk in One Drop of BloodNews
A team of international researchers led by Professor Martin Hegner, Investigator in CRANN and Trinity’s School of Physics, have developed an automated diagnostic platform that can quantify bleeding – and thrombotic risks – in a single drop of blood, within seconds.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE